| Index | - | P/E | 29.29 | EPS (ttm) | 6.68 | Insider Own | 4.58% | Shs Outstand | 15.91M | Perf Week | 11.91% |
| Market Cap | 3.11B | Forward P/E | 18.48 | EPS next Y | 10.59 | Insider Trans | -4.13% | Shs Float | 15.53M | Perf Month | 24.12% |
| Enterprise Value | 3.95B | PEG | 5.41 | EPS next Q | - | Inst Own | - | Short Float | 5.30% | Perf Quarter | 67.96% |
| Income | 115.00M | P/S | 1.72 | EPS this Y | 20.65% | Inst Trans | - | Short Ratio | 2.97 | Perf Half Y | 54.68% |
| Sales | 1.81B | P/B | 8.09 | EPS next Y | 15.13% | ROA | 7.03% | Short Interest | 822.87K | Perf YTD | 13.17% |
| Book/sh | 24.20 | P/C | 100.44 | EPS next 5Y | 5.41% | ROE | 25.53% | 52W High | 203.38 -3.78% | Perf Year | 28.36% |
| Cash/sh | 1.95 | P/FCF | 19.34 | EPS past 3/5Y | 17.07% - | ROIC | 11.19% | 52W Low | 84.88 130.55% | Perf 3Y | 91.95% |
| Dividend Est. | - | EV/EBITDA | 16.87 | Sales past 3/5Y | 14.49% 15.02% | Gross Margin | 30.49% | Volatility | 3.98% 3.59% | Perf 5Y | 281.46% |
| Dividend TTM | - | EV/Sales | 2.18 | EPS Y/Y TTM | 6.54% | Oper. Margin | 11.38% | ATR (14) | 6.63 | Perf 10Y | 249.76% |
| Dividend Ex-Date | - | Quick Ratio | 1.71 | Sales Y/Y TTM | 21.80% | Profit Margin | 6.38% | RSI (14) | 80.26 | Recom | 2.00 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.71 | EPS Q/Q | 30.16% | SMA20 | 14.75% | Beta | 0.12 | Target Price | 184.00 |
| Payout | 0.00% | Debt/Eq | 1.01 | Sales Q/Q | 17.87% | SMA50 | 20.79% | Rel Volume | 2.65 | Prev Close | 193.35 |
| Employees | 9,248 | LT Debt/Eq | 0.97 | Earnings | Nov 03 | SMA200 | 41.86% | Avg Volume | 292.64K | Price | 195.69 |
| IPO Date | Oct 13, 2004 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 13.20% 3.71% | Net Debt/EBITDA | 3.56 | Volume | 776,435 | Change | 1.21% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-30-26 | Reiterated | Barrington | Outperform | $207 → $213 |
| Jun-09-26 | Reiterated | Truist Securities | Buy | $240 → $155 |
| Apr-09-26 | Reiterated | Wedbush | Outperform | $200 → $160 |
| Jan-12-26 | Reiterated | Wedbush | Outperform | $165 → $200 |
| Nov-14-25 | Reiterated | Truist Securities | Buy | $180 → $240 |
| Oct-30-25 | Reiterated | Barrington | Outperform | $176 → $190 |
| Mar-26-25 | Reiterated | Wedbush | Outperform | $150 → $165 |
| Mar-04-25 | Reiterated | Truist Securities | Buy | $140 → $180 |
| Feb-03-25 | Reiterated | Wedbush | $150 | |
| Oct-16-24 | Reiterated | Truist Financial | Buy | $140 |
Huron Consulting Group Inc. provides global professional services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The company offers financial and operational performance improvement consulting services; digital services; spanning technology and analytic-related services, including enterprise health record, enterprise resource planning, enterprise performance management, customer relationship management, data management, artificial intelligence and automation, technology managed services, and a portfolio of software products; organizational transformation; revenue cycle managed services and outsourcing; financial and capital advisory consulting; and strategy and innovation consulting. It also provides research-focused consulting and managed services, as well as Huron Research product suite, a software suite designed to facilitate and improve research administration service delivery and compliance. In addition, the company offers software products, financial capital advisory services, regulatory compliance and risk management consulting, and Commercial consulting. The company serves healthcare, education, financial services, industrials and manufacturing, energy and utilities, public sector, and other commercial industries. The company was incorporated in 2002 and is headquartered in Chicago, Illinois.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,810 | 1,699 | 1,486 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,258 | 1,190 | 1,010 | — | — | — | — | — | — | |
| Gross Profit | 552 | 509 | 476 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 335 | 309 | 284 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 8 | — | — | — | — | — | — | |
| Other Operating Expense | 11 | 0 | 15 | — | — | — | — | — | — | |
| Operating Income | 206 | 199 | 169 | — | — | — | — | — | — | |
| Interest Expense | 40 | 34 | 25 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -10 | -30 | 11 | — | — | — | — | — | — | |
| Net Income Before Taxes | 156 | 135 | 154 | — | — | — | — | — | — | |
| Income Taxes | 41 | 30 | 37 | — | — | — | — | — | — | |
| Consolidated Net Income | 115 | 105 | 117 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 115 | 105 | 117 | — | — | — | — | — | — | |
| Net Income | 115 | 105 | 117 | — | — | — | — | — | — | |
| EPS (Recurring) | 6.82 | 6.02 | 6.52 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 6.82 | 6.02 | 6.52 | — | — | — | — | — | — | |
| EPS (Diluted) | 6.68 | 5.84 | 6.27 | — | — | — | — | — | — | |
| EBITDA | 234 | 202 | 192 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 29.29 | 29.61 | 19.82 | — | — | — | — | — | — | |
| Price To Sales Ratio | 1.73 | 1.73 | 1.51 | — | — | — | — | — | — | |
| Gross Margin | 30.50 | 29.96 | 32.03 | — | — | — | — | — | — | |
| Operating Margin | 11.38 | 11.71 | 11.37 | — | — | — | — | — | — | |
| Net Margin | 6.35 | 6.18 | 7.87 | — | — | — | — | — | — | |
| Shares Outstanding | 16 | 17 | 18 | — | — | — | — | — | — | |
| Market Capitalization | 3,131 | 2,939 | 2,237 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Zumwalt Debra | Director | Oct 02 '26 | Sale | 167.75 | 82 | 13,756 | 27,037 | Oct 06 |
| Zumwalt Debra | Director | Aug 14 '26 | Sale | 156.56 | 82 | 12,838 | 27,119 | Aug 18 |
| SAWYER HUGH E III | Director | Aug 11 '26 | Sale | 154.25 | 2,000 | 308,500 | 20,490 | Aug 13 |
| Featherstone Kyle | Chief Acct Officer, Controller | Jul 31 '26 | Sale | 152.67 | 459 | 70,076 | 1,050 | Aug 03 |
| Hussey C. Mark | CEO and President | Jul 29 '26 | Sale | 165.59 | 24,072 | 3,986,172 | 74,399 | Jul 31 |
| Brown Joy | Director | May 22 '26 | Sale | 105.01 | 1,821 | 191,231 | 8,575 | May 27 |
| Singh-Bushell Ekta | Director | May 11 '26 | Sale | 118.44 | 443 | 52,469 | 13,646 | May 13 |
| Zumwalt Debra | Director | May 11 '26 | Sale | 118.44 | 598 | 70,827 | 27,201 | May 13 |
| MCCARTNEY JOHN | Director | May 01 '26 | Sale | 132.04 | 500 | 66,020 | 40,317 | May 05 |
| Singh-Bushell Ekta | Director | Apr 02 '26 | Sale | 126.93 | 126 | 15,993 | 14,089 | Apr 06 |
| Zumwalt Debra | Director | Apr 02 '26 | Sale | 126.93 | 170 | 21,578 | 26,299 | Apr 06 |
| MCCARTNEY JOHN | Director | Apr 01 '26 | Sale | 127.68 | 500 | 63,840 | 40,817 | Apr 03 |
| MCCARTNEY JOHN | Director | Mar 02 '26 | Sale | 139.15 | 500 | 69,575 | 41,317 | Mar 03 |
| SAWYER HUGH E III | Director | Feb 02 '26 | Sale | 168.77 | 400 | 67,508 | 20,990 | Feb 04 |
| MCCARTNEY JOHN | Director | Feb 02 '26 | Sale | 168.77 | 500 | 84,385 | 41,817 | Feb 04 |